Article
Endophenotype-based polygenic risk scores: Prediction of biomarker and clinical progression and dementia
2022-09-28
Abstract excerpt
<title>Abstract</title> <p>BACKGROUND: Biomarkers provide a framework for a biological diagnosis of Alzheimer’s disease (AD) whereas polygenic risk scores (PRS) provide method to estimate genetic risk. We derive biomarker-based PRS by incorporating endophenotype genetic risk relevant to amyloid, tau, neurodegeneration and cerebrovascular (A/T/N/V) pathology. METHODS: Endophenotype-PRSs (PRS<sub>A</sub>, PRS<sub>T...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b0c1f450-e737-5644-b002-5eea7d5af733
- DOI
- 10.21203/rs.3.rs-2092941/v1
